| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 373.9K | $355.2K | +13.0K | |
| CFO | 87.8K | $83.4K | - | |
| VP | 61.1K | $58.1K | - | |
| Dir | 23.7K | $22.5K | - | |
| Dir | 23.6K | $22.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Altman Peter46 | President And CEO | Buy | 5,000 | $0.78 | $3,900.00 | +1.4% | - | - | |
| Jul 17, 2026 | Altman Peter46 | President And CEO | Buy | 500 | $0.83 | $415.00 | +0.1% | - | - | |
| Jul 10, 2026 | Altman Peter46 | President And CEO | Buy | 7,500 | $0.96 | $7,175.00 | +0.7% | - | - | |
| Jun 23, 2026 | Stertzer Simon H | Director | Buy | 109,200 | $0.95 | $103,584.00 | +59.2% | - | - | |
| May 20, 2026 | Altman Peter46 | President And CEO | Buy | 1,700 | $0.92 | $1,570.00 | +0.3% | - | - | |
| May 18, 2026 | Altman Peter46 | President And CEO | Buy | 5,700 | $0.92 | $5,244.00 | +2.0% | - | - | |
| Apr 29, 2026 | Altman Peter46 | President And CEO | Buy | 5,000 | $1.11 | $5,550.00 | +1.8% | -29.1% | - | |
| Apr 21, 2026 | Altman Peter46 | President And CEO | Buy | 1,000 | $1.23 | $1,230.00 | +0.2% | -28.8% | - | |
| Mar 25, 2026 | Altman Peter46 | President And CEO | Buy | 900 | $1.23 | $1,110.00 | +0.2% | -16.7% | - | |
| Jan 21, 2026 | Altman Peter46 | President And CEO | Buy | 900 | $1.33 | $1,194.00 | +0.2% | - | - |